Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 2,061,100 | 1,803,900 | 1,698,300 | 1,783,300 | 1,799,800 |
| Cost of Goods | 592,400 | 502,900 | 505,100 | 518,000 | 494,100 |
| Gross Profit | 1,468,700 | 1,301,000 | 1,193,200 | 1,265,300 | 1,305,700 |
| Operating Expenses | 929,600 | 764,700 | 752,500 | 736,000 | 851,000 |
| Operating Income | 539,500 | 537,200 | 440,800 | 529,300 | 454,800 |
| Interest Expense | 69,300 | 74,100 | 75,500 | 69,900 | 72,200 |
| Other Income | 12,600 | 96,300 | 100,000 | 64,400 | -18,800 |
| Pre-tax Income | 482,800 | 559,400 | 465,300 | 523,800 | 363,800 |
| Income Tax | 109,800 | 143,800 | 119,600 | 134,600 | 52,500 |
| Net Income Continuous | 373,000 | 415,600 | 345,700 | 389,200 | 311,300 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | 31,300 |
| Net Income | $373,000 | $415,600 | $345,700 | $389,200 | $342,600 |
| EPS Basic Total Ops | 0.34 | 0.38 | 0.32 | 0.36 | 0.32 |
| EPS Basic Continuous Ops | 0.34 | 0.38 | 0.32 | 0.36 | 0.28 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.03 |
| EPS Diluted Total Ops | 0.34 | 0.38 | 0.32 | 0.36 | 0.32 |
| EPS Diluted Continuous Ops | 0.34 | 0.38 | 0.32 | 0.36 | 0.28 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.03 |
| EBITDA(a) | $678,200 | $673,100 | $577,000 | $662,000 | $454,800 |